SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 93 filers reported holding SAGENT PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,218,000 | +24.8% | 81,284 | +1.4% | 0.00% | +100.0% |
| Q1 2016 | $976,000 | -13.9% | 80,150 | +12.5% | 0.00% | -50.0% |
| Q4 2015 | $1,134,000 | -10.4% | 71,273 | -13.6% | 0.00% | 0.0% |
| Q3 2015 | $1,266,000 | -73.9% | 82,532 | -58.7% | 0.00% | -71.4% |
| Q2 2015 | $4,855,000 | -14.8% | 199,712 | -18.5% | 0.01% | -12.5% |
| Q1 2015 | $5,696,000 | -13.1% | 244,970 | -6.1% | 0.01% | -20.0% |
| Q4 2014 | $6,551,000 | -19.4% | 260,886 | -0.1% | 0.01% | -23.1% |
| Q3 2014 | $8,124,000 | +22.8% | 261,212 | +2.1% | 0.01% | +18.2% |
| Q2 2014 | $6,615,000 | +10.5% | 255,775 | -0.1% | 0.01% | 0.0% |
| Q1 2014 | $5,987,000 | -7.4% | 256,143 | +0.5% | 0.01% | -8.3% |
| Q4 2013 | $6,466,000 | +30.5% | 254,763 | +5.9% | 0.01% | +20.0% |
| Q3 2013 | $4,956,000 | +217.5% | 240,537 | +229.4% | 0.01% | +233.3% |
| Q2 2013 | $1,561,000 | – | 73,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
| Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
| Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
| Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
| MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
| KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
| Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |